| [1] |
Yu Z, Xu Z, Liang Y, et al. Vitamin C deficiency causes cell type-specific epigenetic reprogramming and acute tubular necrosis in a mouse model [J]. J Am Soc Nephrol, 2022, 33(3): 531-546.
|
| [2] |
De Chiara L, Conte C, Semeraro R, et al. Tubular cell polyploidy protects from lethal acute kidney injury but promotes consequent chronic kidney disease [J]. Nat Commun, 2022, 13(1): 5805.
|
| [3] |
Martin-Saiz L, Guerrero-Mauvecin J, Martin-Sanchez D, et al. Ferrostatin-1 modulates dysregulated kidney lipids in acute kidney injury [J]. J Pathol, 2022, 257(3): 285-299.
|
| [4] |
von Massenhausen A, Zamora Gonzalez N, Maremonti F, et al. Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion [J]. Sci Adv, 2022, 8(5): eabl8920.
|
| [5] |
Sako K, Furuichi K, Makiishi S, et al. Cyclin-dependent kinase 4-related tubular epithelial cell proliferation is regulated by paired box gene 2 in kidney ischemia-reperfusion injury [J]. Kidney Int, 2022, 102(1): 45-57.
|
| [6] |
Shin NS, Marlier A, Xu L, et al. Arginase-1 is required for macrophage-mediated renal tubule regeneration [J]. J Am Soc Nephrol, 2022, 33(6): 1077-1086.
|
| [7] |
Shi M, Maique J, Shepard S, et al. In vivo evidence for therapeutic applications of beclin 1 to promote recovery and inhibit fibrosis after acute kidney injury [J]. Kidney Int, 2022, 101(1): 63-78.
|
| [8] |
Chen JW, Huang MJ, Chen XN, et al. Transient upregulation of EGR1 signaling enhances kidney repair by activating SOX9+ renal tubular cells [J]. Theranostics, 2022, 12(12): 5434-5450.
|
| [9] |
Klocke J, Kim SJ, Skopnik CM, et al. Urinary single-cell sequencing captures kidney injury and repair processes in human acute kidney injury [J]. Kidney Int, 2022, 102(6): 1359-1370.
|
| [10] |
Vallorz EL, Janda J, Mansour HM, et al. Kidney targeting of formoterol containing polymeric nanoparticles improves recovery from ischemia reperfusion-induced acute kidney injury in mice [J]. Kidney Int, 2022, 102(5): 1073-1089.
|
| [11] |
Thomas K, Zondler L, Ludwig N, et al. Glutamine prevents acute kidney injury by modulating oxidative stress and apoptosis in tubular epithelial cells [J]. JCI Insight, 2022, 7(21): e163161.
|
| [12] |
Valino-Rivas L, Cuarental L, Ceballos MI, et al. Growth differentiation factor-15 preserves klotho expression in acute kidney injury and kidney fibrosis [J]. Kidney Int, 2022, 101(6): 1200-1215.
|
| [13] |
Yao W, Chen Y, Li Z, et al. Single cell RNA sequencing identifies a unique inflammatory macrophage subset as a druggable target for alleviating acute kidney injury [J]. Adv Sci (Weinh), 2022, 9(12): e2103675.
|
| [14] |
Lau A, Rahn JJ, Chappellaz M, et al. Dipeptidase-1 governs renal inflammation during ischemia reperfusion injury [J]. Sci Adv, 2022, 8(5): eabm0142.
|
| [15] |
Pan Y, Cao S, Terker AS, et al. Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injury [J]. Kidney Int, 2022, 101(1): 79-91.
|
| [16] |
Leng J, Zhao W, Guo J, et al. E-prostanoid 3 receptor deficiency on myeloid cells protects against ischemic acute kidney injury via breaking the auto-amplification loop of necroinflammation [J]. Kidney Int, 2023, 103(1): 100-114.
|
| [17] |
Martin-Sanchez D, Guerrero-Mauvecin J, Fontecha-Barriuso M, et al. Bone marrow-derived RIPK3 mediates kidney inflammation in acute kidney injury [J]. J Am Soc Nephrol, 2022, 33(2): 357-373.
|
| [18] |
Baatarjav C, Komada T, Karasawa T, et al. dsDNA-induced AIM2 pyroptosis halts aberrant inflammation during rhabdomyolysis-induced acute kidney injury [J]. Cell Death Differ, 2022, 29(12): 2487-2502.
|
| [19] |
Privratsky JR, Ide S, Chen Y, et al. A macrophage-endothelial immunoregulatory axis ameliorates septic acute kidney injury [J]. Kidney Int, 2023, 103(3): 514-528.
|
| [20] |
Cai A, Ye G, Placier S, et al. Genetic inactivation of semaphorin 3C protects mice from acute kidney injury [J]. Kidney Int, 2022, 101(4): 720-732.
|
| [21] |
Tanaka T, Kavsur R, Sugiura A, et al. Acute kidney injury following tricuspid transcatheter edge-to-edge repair [J]. JACC Cardiovasc Interv, 2022, 15(19): 1936-1945.
|
| [22] |
Koh HB, Jung CY, Kim HW, et al. Preoperative ionized magnesium levels and risk of acute kidney injury after cardiac surgery [J]. Am J Kidney Dis, 2022, 80(5): e629-e637.
|
| [23] |
Murphy CF, Dunne T, Elliott JA, et al. Acute kidney injury after esophageal cancer surgery: incidence, risk factors, and impact on oncologic outcomes [J]. Ann Surg, 2022, 275(5): e683-e689.
|
| [24] |
Ozrazgat-Baslanti T, Loftus TJ, Mohandas R, et al. Clinical trajectories of acute kidney injury in surgical sepsis: a prospective observational study [J]. Ann Surg, 2022, 275(6): 1184-1193.
|
| [25] |
Molinari L, Del Rio-Pertuz G, Smith A, et al. Utility of biomarkers for sepsis-associated acute kidney injury staging [J]. JAMA Netw Open, 2022, 5(5): e2212709.
|
| [26] |
Mohebi R, Karimi Galougahi K, Garcia JJ, et al. Long-term clinical impact of contrast-associated acute kidney injury following PCI: an ADAPT-DES substudy [J]. JACC Cardiovasc Interv, 2022, 15(7): 753-766.
|
| [27] |
Tergast TL, Schulte B, Griemsmann M, et al. Application of CT contrast medium is not associated with an increased risk for acute kidney injury in patients with decompensated cirrhosis [J]. Aliment Pharmacol Ther, 2023, 57(1): 136-145.
|
| [28] |
Baker ML, Yamamoto Y, Perazella MA, et al. Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy [J]. J Immunother Cancer, 2022, 10(3): e004421.
|
| [29] |
Gupta S, Garcia-Carro C, Prosek JM, et al. Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI [J]. J Immunother Cancer, 2022, 10(9): e005646.
|
| [30] |
Collaborative ST. Perioperative nonsteroidal anti-inflammatory drugs (NSAID) administration and acute kidney injury (AKI) in major gastrointestinal surgery: a prospective, multicenter, propensity matched cohort study [J]. Ann Surg, 2022, 275(5): 904-910.
|
| [31] |
Jiang G, Luk AO, Tam CHT, et al. Clinical predictors and long-term impact of acute kidney injury on progression of diabetic kidney disease in Chinese patients with type 2 diabetes [J]. Diabetes, 2022, 71(3): 520-529.
|
| [32] |
Farooqui N, Sy-Go JPT, Miao J, et al. Incidence and risk factors for acute kidney injury after chimeric antigen receptor t-cell therapy [J]. Mayo Clin Proc, 2022, 97(7): 1294-1304.
|
| [33] |
Patidar KR, Naved MA, Grama A, et al. Acute kidney disease is common and associated with poor outcomes in patients with cirrhosis and acute kidney injury [J]. J Hepatol, 2022, 77(1): 108-115.
|
| [34] |
Shapiro J, Ray JG, McArthur E, et al. Risk of acute kidney injury after hypertensive disorders of pregnancy: a population-based cohort study [J]. Am J Kidney Dis, 2022, 79(4): 561-569.
|
| [35] |
Batte A, Menon S, Ssenkusu JM, et al. Neutrophil gelatinase-associated lipocalin is elevated in children with acute kidney injury and sickle cell anemia, and predicts mortality [J]. Kidney Int, 2022, 102(4): 885-893.
|
| [36] |
Gambino C, Piano S, Stenico M, et al. Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury [J]. Hepatology, 2022, Epub ahead of print.
|
| [37] |
Wilson M, Packington R, Sewell H, et al. Biomarkers during recovery from AKI and prediction of long-term reductions in estimated GFR [J]. Am J Kidney Dis, 2022, 79(5): 646-656.
|
| [38] |
Pan HC, Yang SY, Chiou TT, et al. Comparative accuracy of biomarkers for the prediction of hospital-acquired acute kidney injury: a systematic review and meta-analysis [J]. Crit Care, 2022, 26(1): 349.
|
| [39] |
Demirjian S, Bashour CA, Shaw A, et al. Predictive accuracy of a perioperative laboratory test-based prediction model for moderate to severe acute kidney injury after cardiac surgery [J]. JAMA, 2022, 327(10): 956-964.
|
| [40] |
Neyra JA, Ortiz-Soriano V, Liu LJ, et al. Prediction of mortality and major adverse kidney events in critically ill patients with acute kidney injury [J]. Am J Kidney Dis, 2023, 81(1): 36-47.
|
| [41] |
Hinze C, Kocks C, Leiz J, et al. Single-cell transcriptomics reveals common epithelial response patterns in human acute kidney injury [J]. Genome Med, 2022, 14(1): 103.
|
| [42] |
James MT, Har BJ, Tyrrell BD, et al. Effect of clinical decision support with audit and feedback on prevention of acute kidney injury in patients undergoing coronary angiography: a randomized clinical trial [J]. JAMA, 2022, 328(9): 839-849.
|
| [43] |
Zhuo M, Paik JM, Wexler DJ, et al. SGLT2 inhibitors and the risk of acute kidney injury in older adults with type 2 diabetes [J]. Am J Kidney Dis, 2022, 79(6): 858-867.
|
| [44] |
Bagshaw SM, Neto AS, Smith O, et al. Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial [J]. Intensive Care Med, 2022, 48(12): 1736-1750.
|
| [45] |
Gaudry S, Grolleau F, Barbar S, et al. Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL -ICU studies [J]. Crit Care, 2022, 26(1): 93.
|
| [46] |
Wang W, Chen J, Hu D, et al. SARS-CoV-2 N protein induces acute kidney injury via Smad3-dependent G1 cell cycle arrest mechanism [J]. Adv Sci (Weinh), 2022, 9(3): e2103248.
|
| [47] |
Hassler L, Wysocki J, Gelarden I, et al. A novel soluble ACE2 protein provides lung and kidney protection in mice susceptible to lethal SARS-CoV-2 infection [J]. J Am Soc Nephrol, 2022, 33(7): 1293-1307.
|
| [48] |
Rahmani W, Chung H, Sinha S, et al. Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids [J]. iScience, 2022, 25(2): 103818.
|
| [49] |
Hsu CM, Gupta S, Tighiouart H, et al. Kidney recovery and death in critically ill patients with COVID-19-associated acute kidney injury treated with dialysis: the STOP-COVID cohort study [J]. Am J Kidney Dis, 2022, 79(3): 404-416.
|